Nieuwsfeed
- Your weekly roundup of STAT's First Opinion
- TrialSite News Daily Digest
- Weekend reads: Chair leaves post during investigation of double-dipping allegations; geoscientist fined; prof claims another’s papers are hers
- Weekend reads: Chair leaves post during investigation of double-dipping allegations; geoscientist fined; prof claims another’s papers are hers
- 'Rock star' potential for deploying viruses against cancer
- TrialSite News Daily Digest
- All about Omicron; We need more Covid antivirals; GSK snags Pfizer’s vaccine exec; Janet Woodcock’s future at FDA; and more
- This Week at FDA: Pediatric use for Lilly’s COVID mAbs; Will Woodcock stay on?
- AHA “regrets any confusion” and is reviewing meeting policies after outcry over Covid-19 vaccine abstract
- How to interpret the coming flood of Omicron data; why it took so long to find the variant in the U.S.
- Stoke Therapeutics drug reduces seizure activity & and a flood of data on Omicron
- AbbVie tacks on a new warning to Rinvoq label as safety frets crimp JAK class
- Human Drug Export Certificate Application Instructions
- Thankful for nurses: Johnson & Johnson's new campaign aims to reset pandemic clock back to gratitude
- Uitgelicht en gespot op internet (week 45, 46, 47 & 48, 2021)